V. Reddy

发表

A Preliminary Gene Expression Profile of Acute Graft-Versus-Host Disease

George Casella, G. Casella, M. Buzzeo, 2008, Cell transplantation.

Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease.

J. Schold, J. Wingard, H. Meier‐Kriesche, 2004, Blood.

Spiritual absence and 1-year mortality after hematopoietic stem cell transplant.

J. Wingard, Michelle Bishop, L. Christian, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte-macrophage colony-stimulating factor increases the proportion of circulating dendritic cells after autologous but not after allogeneic hematopoietic stem cell transplantation.

S. Eisen, E. Eksioglu, V. Reddy, 2011, Cytotherapy.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

W. Wood, M. Sorror, M. Aljurf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.

L. Bouzas, D. Parenti, A. Elmaagacli, 2008, Blood.

Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1

D. Miklos, Stephanie J. Lee, M. Heemskerk, 2014, Bone Marrow Transplantation.

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

J. Pidala, S. Santarone, Stephanie J. Lee, 2013, Blood.

Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

J. Schold, J. Wingard, H. Meier‐Kriesche, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.

Jeffrey A Jones, J. Byrd, A. Zelenetz, 2019, The Lancet. Haematology.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

J. Lipton, H. Greinix, D. Vesole, 2007, The New England journal of medicine.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study

E. Guinan, M. Boeckh, M. Aljurf, 2016, Bone Marrow Transplantation.

Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy Using Topotecan Followed by Etoposide+Mitoxantrone (T-EM) and Correlation with Topoisomerase II Levels

L. Rimsza, R. Braylan, J. Wingard, 2002, Leukemia & lymphoma.

Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy.

M. Minden, T. Mazzulli, H. Messner, 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

J. Wingard, P. Mehta, V. Reddy, 2002, Bone Marrow Transplantation.

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

J. Wingard, C. Cogle, J. Moreb, 2003, American journal of hematology.

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis

J. Byrd, U. Jaeger, T. Shanafelt, 2018, British journal of haematology.

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.

G. Hill, D. Bungard, J. Ferrara, 1999, Blood.

RAPID COMMUNICATION Granulocyte Colony-Stimulating Factor–Mobilized Allogeneic Stem Cell Transplantation Maintains Graft-Versus-Leukemia Effects Through a Perforin-Dependent Pathway While Preventing Graft-Versus-Host Disease

G. Hill, D. Bungard, J. Ferrara, 2022 .

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

R. Gale, P. Tiberghien, O. Ringdén, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.

G. Hill, J. Ferrara, L. Pan, 2000, Transplantation.

Prognostic correlation of increased angiogenesis in acute myeloid leukemia with cytogenetics.

J. Moreb, V. Reddy, 2000, Blood.

Dendritic cells as therapeutic agents against cancer.

Vijay Reddy, Erika A Eksioglu, S. Eisen, 2010, Frontiers in bioscience.

GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.

Myron N. Chang, E. Eksioglu, V. Reddy, 2007, Experimental hematology.

Granulocyte colony-stimulating factor mobilization alters dendritic cell cytokine production and initiates T helper 2 polarization prior to host alloantigen presentation.

V. Reddy, 2000, Blood.

Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment.

V. Reddy, Dunsong Yang, K. Winslow, 2007, Fertility and sterility.

PHYSICIAN PERCEPTIONS AND PRACTICE PATTERNS REGARDING FERTILITY PRESERVATION IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

M. Sorror, J. Wingard, J. Pidala, 2013, Bone Marrow Transplantation.

Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.

D. Parenti, A. Elmaagacli, K. van Besien, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

J. Schold, J. Wingard, H. Meier‐Kriesche, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Potential therapeutic role of natural killer cells in cancer

K. Woan, V. Reddy, Karrune V. Woan, 2007, Expert opinion on biological therapy.

Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

A. Ganser, D. Miklos, M. Aljurf, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ABO blood group barrier in allogeneic bone marrow transplantation revisited.

A. Barrett, M. Horowitz, R. Gale, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma

T. Panzarella, J. Lipton, A. Schimmer, 2003, Bone Marrow Transplantation.

Conditioning regimen Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma

T. Panzarella, A. Schimmer, H. Messner, 2003 .

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Tao Wang, John Horan, Machteld Oudshoorn, 2012, Blood.

Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Zhiwei, Saber, M. Norkin, 2014 .

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis.

George Casella, G. Casella, M. Buzzeo, 2007, Experimental hematology.

High Rates of Transplantation in the Phase III Sierra Trial Utilizing Anti-CD45 (Iodine) 131I-Apamistamab (Iomab-B) Conditioning with Successful Engraftment and Tolerability in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) Patients after Lack of Response to Conventional Care and Targeted Th

M. Berger, P. Hari, K. van Besien, 2022, Transplantation and Cellular Therapy.

Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT

J. Schold, J. Wingard, R. Amdur, 2010, Bone Marrow Transplantation.

Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT

M. Solh, V. Reddy, Y. Khaled, 2013, Bone Marrow Transplantation.

A Randomized Single−Blind Study of Extracorporeal Photopheresis with UVADEX® Plus Conventional Therapy (CT) Compared to CT Alone in Chronic GVHD.

L. Bouzas, A. Elmaagacli, H. Greinix, 2006 .

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

D. Ward, V. Reddy, P. Farnsworth, 2012, Experimental Hematology & Oncology.

A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia Applicable to Patients Treated with Novel Therapies and Standard of Care

Jeffrey A Jones, J. Byrd, A. Zelenetz, 2017 .

Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations.

J. Wingard, P. Mehta, V. Reddy, 1999, Blood.

Infections post transplant Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

J. Wingard, P. Mehta, C. Clancy, 2002 .

Targeted Conditioning of Iomab-B (131I-anti-CD45) Prior to Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care in Relapsed or Refractory Acute Myeloid Leukemia (AML): Preliminary Feasibility and Safety Results from the Prospective, Randomized Phase 3 Sierra Trial

M. Berger, J. Pagel, H. Lazarus, 2018, Blood.

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN

W. Wood, M. Sorror, J. Wingard, 2012, Bone Marrow Transplantation.

Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.

D. Parenti, A. Elmaagacli, K. van Besien, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.

Stephanie J. Lee, S. Spellman, Tao Wang, 2012, Blood.